1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with flurbiprofen in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (flurbiprofen) | Trials (flurbiprofen) | Recent Studies (post-2010) (flurbiprofen) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 2,072 | 466 | 575 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | flurbiprofen (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.1683 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.6754 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.574 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.56 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.5 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 1.5 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furman, BL; Gray, GA; Parratt, JR | 1 |
| Barnes, PJ; Giembycz, MA; Kroegel, C | 1 |
| Rosenbaum, JT; Rubin, RM | 1 |
| Bárány, M; Kester, M; Ledvora, RF | 1 |
| Rasheed, H; Saeed, SA | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and flurbiprofen
| Article | Year |
|---|---|
Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Cyclooxygenase Inhibitors; Dinoprostone; Electric Stimulation; Endotoxins; Epoprostenol; Flurbiprofen; Hemodynamics; Iloprost; Male; Norepinephrine; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Spinal Cord; Sympathetic Nervous System | 1990 |
Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Topics: Animals; Azepines; Calcimycin; Calcium; Complement C5a; Cyclooxygenase Inhibitors; Enzyme Activation; Eosinophils; Flurbiprofen; Guinea Pigs; Imidazoles; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Superoxides; Tetradecanoylphorbol Acetate; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Triazines; Triazoles | 1990 |
A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation.
Topics: Animals; Aqueous Humor; Capillary Permeability; Dinoprostone; Eye; Female; Flurbiprofen; Inflammation; Interleukin-1; Leukocyte Count; Platelet Activating Factor; Prednisolone; Prostaglandins E; Proteins; Quinolinium Compounds; Rabbits; Recombinant Proteins | 1988 |
The potentiation of arterial contraction with platelet activating factor.
Topics: Animals; Calmodulin; Carotid Arteries; Flurbiprofen; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Activating Factor; Potassium Chloride; Sodium Chloride; Swine; Verapamil | 1984 |
Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Azepines; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Drug Synergism; Epinephrine; Flurbiprofen; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction; Triazoles; Verapamil; Yohimbine | 2003 |